» Articles » PMID: 25411288

Serum Pentadecanoic Acid (15:0), a Short-term Marker of Dairy Food Intake, is Inversely Associated with Incident Type 2 Diabetes and Its Underlying Disorders

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2014 Nov 21
PMID 25411288
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Growing evidence suggests that dairy consumption is associated with lower type 2 diabetes risk. However, observational studies have reported inconsistent results, and few have examined dairy's association with the underlying disorders of insulin resistance and β-cell dysfunction.

Objective: We investigated the association of the dairy fatty acid biomarkers pentadecanoic acid (15:0) and trans-palmitoleic acid (trans 16:1n-7) with type 2 diabetes traits by evaluating 1) prospective associations with incident diabetes after 5 y of follow-up and 2) cross-sectional associations with directly measured insulin resistance and β-cell dysfunction.

Design: The study analyzed 659 adults without diabetes at baseline from the triethnic multicenter Insulin Resistance Atherosclerosis Study (IRAS). Diabetes status was assessed by using oral-glucose-tolerance tests. Frequently sampled intravenous-glucose-tolerance tests measured insulin sensitivity (SI) and β-cell function [disposition index (DI)]. Serum fatty acids were quantified by using gas chromatography. Logistic and linear regression models were adjusted for demographic, lifestyle, and dietary variables.

Results: Serum 15:0 was a significant biomarker for total dairy intake in the IRAS cohort. It was associated with a decreased incident diabetes risk (OR: 0.73, P = 0.02) and was positively associated with log SI (β: 0.84, P = 0.03) and log DI (β: 2.21, P = 0.02) in fully adjusted models. trans 16:1n-7 was a marker of total partially hydrogenated dietary fat intake and was not associated with outcomes in fully adjusted models.

Conclusions: Serum 15:0, a marker of short-term intake of this fatty acid, was inversely associated with diabetes risk in this multiethnic cohort. This study may contribute to future recommendations regarding the benefits of dairy products on type 2 diabetes risk.

Citing Articles

GC/MS Fatty Acid Profile of Marine-Derived Actinomycetes from Extreme Environments: Chemotaxonomic Insights and Biotechnological Potential.

Cunha M, Jorge A, Nunes M, Sousa J, Lanca M, Gomes da Silva M Mar Drugs. 2025; 23(1).

PMID: 39852503 PMC: 11767043. DOI: 10.3390/md23010001.


Translational Algorithms for Technological Dietary Quality Assessment Integrating Nutrimetabolic Data with Machine Learning Methods.

de la O V, Fernandez-Cruz E, Matia Matin P, Larrad-Sainz A, Espadas Gil J, Barabash A Nutrients. 2024; 16(22).

PMID: 39599604 PMC: 11597732. DOI: 10.3390/nu16223817.


Galactooligosaccharides and Limosilactobacillus reuteri synergistically alleviate gut inflammation and barrier dysfunction by enriching Bacteroides acidifaciens for pentadecanoic acid biosynthesis.

Wu Y, Zhang X, Liu X, Zhao Z, Tao S, Xu Q Nat Commun. 2024; 15(1):9291.

PMID: 39468026 PMC: 11519483. DOI: 10.1038/s41467-024-53144-1.


Cow's Milk Bioactive Molecules in the Regulation of Glucose Homeostasis in Human and Animal Studies.

Yuzbashian E, Berg E, de Campos Zani S, Chan C Foods. 2024; 13(17).

PMID: 39272602 PMC: 11395457. DOI: 10.3390/foods13172837.


Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds.

Venn-Watson S, Schork N Nutrients. 2023; 15(21).

PMID: 37960259 PMC: 10649853. DOI: 10.3390/nu15214607.


References
1.
Elwood P, Pickering J, Fehily A . Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J Epidemiol Community Health. 2007; 61(8):695-8. PMC: 2652996. DOI: 10.1136/jech.2006.053157. View

2.
Sun Q, Ma J, Campos H, Hu F . Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. Am J Clin Nutr. 2007; 86(4):929-37. DOI: 10.1093/ajcn/86.4.929. View

3.
Kratz M, Marcovina S, Nelson J, Yeh M, Kowdley K, Callahan H . Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans. Am J Clin Nutr. 2014; 99(6):1385-96. PMC: 4021783. DOI: 10.3945/ajcn.113.075457. View

4.
Aune D, Norat T, Romundstad P, Vatten L . Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr. 2013; 98(4):1066-83. DOI: 10.3945/ajcn.113.059030. View

5.
Louie J, Flood V, Rangan A, Burlutsky G, Gill T, Gopinath B . Higher regular fat dairy consumption is associated with lower incidence of metabolic syndrome but not type 2 diabetes. Nutr Metab Cardiovasc Dis. 2012; 23(9):816-21. DOI: 10.1016/j.numecd.2012.08.004. View